COMPANIES COVERED
Eli LillyDownload FREE Report Sample
Download Free sampleHormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.
Hormone Replacement Therapy Market contains market size and forecasts of Hormone Replacement Therapy (HRT) in Global, including the following market information:
Global Hormone Replacement Therapy (HRT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hormone Replacement Therapy (HRT) market was valued at 3832.9 million in 2021 and is projected to reach US$ 4985.8 million by 2028, at a CAGR of 3.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Estrogen Hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hormone Replacement Therapy (HRT) include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck, Mylan, Bayer, Teva and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hormone Replacement Therapy (HRT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hormone Replacement Therapy (HRT) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hormone Replacement Therapy (HRT) Market Segment Percentages, by Type, 2021 (%)
Estrogen Hormone
Growth Hormone
Thyroid Hormone
Testosterone Hormone
Global Hormone Replacement Therapy (HRT) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hormone Replacement Therapy (HRT) Market Segment Percentages, by Application, 2021 (%)
Menopause
Hypothyroidism
Growth Hormone Deficiency
Male Hypogonadism
Other Diseases
Global Hormone Replacement Therapy (HRT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hormone Replacement Therapy (HRT) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hormone Replacement Therapy (HRT) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hormone Replacement Therapy (HRT) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
